These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1458 related articles for article (PubMed ID: 32330277)

  • 21. Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population.
    Yao X; Hou Z; Cui C; Zhang M; Tu S; Li H; Liu D
    Curr Drug Metab; 2020; 21(7):534-540. PubMed ID: 32651961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.
    Lian N; Xie H; Lin S; Huang J; Zhao J; Lin Q
    Clin Microbiol Infect; 2020 Jul; 26(7):917-921. PubMed ID: 32344167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 trial of i.v. citicoline (CDP-choline) in hospitalized SARS CoV-2-infected patients with hypoxemic acute respiratory failure.
    Pannu S; Exline MC; Bednash JS; Englert JA; Diaz P; Bartlett A; Brock G; Wu Q; Davis IC; Crouser ED
    Trials; 2024 May; 25(1):328. PubMed ID: 38760804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concentration-dependent mortality of chloroquine in overdose.
    Watson JA; Tarning J; Hoglund RM; Baud FJ; Megarbane B; Clemessy JL; White NJ
    Elife; 2020 Jul; 9():. PubMed ID: 32639233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.
    Giaime P; Guenoun M; Pedinielli N; Narbonne H; Bergounioux JP; Solas C; Guilhaumou R; Sampol J; Ollier J; Sichez H; Serveaux M; Brunner F; Bataille S
    Nephrol Dial Transplant; 2020 Aug; 35(8):1346-1353. PubMed ID: 32844224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
    Devaux CA; Rolain JM; Colson P; Raoult D
    Int J Antimicrob Agents; 2020 May; 55(5):105938. PubMed ID: 32171740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study.
    Liu X; Chen H; Shang Y; Zhu H; Chen G; Chen Y; Liu S; Zhou Y; Huang M; Hong Z; Xia J
    Trials; 2020 Jul; 21(1):622. PubMed ID: 32641091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial.
    Jeronimo CMP; Farias MEL; Val FFA; Sampaio VS; Alexandre MAA; Melo GC; Safe IP; Borba MGS; Netto RLA; Maciel ABS; Neto JRS; Oliveira LB; Figueiredo EFG; Oliveira Dinelly KM; de Almeida Rodrigues MG; Brito M; Mourão MPG; Pivoto João GA; Hajjar LA; Bassat Q; Romero GAS; Naveca FG; Vasconcelos HL; de Araújo Tavares M; Brito-Sousa JD; Costa FTM; Nogueira ML; Baía-da-Silva DC; Xavier MS; Monteiro WM; Lacerda MVG;
    Clin Infect Dis; 2021 May; 72(9):e373-e381. PubMed ID: 32785710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients.
    Réa-Neto Á; Bernardelli RS; Câmara BMD; Reese FB; Queiroga MVO; Oliveira MC
    Sci Rep; 2021 Apr; 11(1):9023. PubMed ID: 33907251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
    Kuderer NM; Choueiri TK; Shah DP; Shyr Y; Rubinstein SM; Rivera DR; Shete S; Hsu CY; Desai A; de Lima Lopes G; Grivas P; Painter CA; Peters S; Thompson MA; Bakouny Z; Batist G; Bekaii-Saab T; Bilen MA; Bouganim N; Larroya MB; Castellano D; Del Prete SA; Doroshow DB; Egan PC; Elkrief A; Farmakiotis D; Flora D; Galsky MD; Glover MJ; Griffiths EA; Gulati AP; Gupta S; Hafez N; Halfdanarson TR; Hawley JE; Hsu E; Kasi A; Khaki AR; Lemmon CA; Lewis C; Logan B; Masters T; McKay RR; Mesa RA; Morgans AK; Mulcahy MF; Panagiotou OA; Peddi P; Pennell NA; Reynolds K; Rosen LR; Rosovsky R; Salazar M; Schmidt A; Shah SA; Shaya JA; Steinharter J; Stockerl-Goldstein KE; Subbiah S; Vinh DC; Wehbe FH; Weissmann LB; Wu JT; Wulff-Burchfield E; Xie Z; Yeh A; Yu PP; Zhou AY; Zubiri L; Mishra S; Lyman GH; Rini BI; Warner JL;
    Lancet; 2020 Jun; 395(10241):1907-1918. PubMed ID: 32473681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chloroquine phosphate: therapeutic drug for COVID-19].
    Mo L; Zheng P
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Apr; 40(4):586-594. PubMed ID: 32895128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.
    Klimke A; Hefner G; Will B; Voss U
    Med Hypotheses; 2020 Sep; 142():109783. PubMed ID: 32402766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 Randomized Clinical Trial.
    Cairns DM; Dulko D; Griffiths JK; Golan Y; Cohen T; Trinquart L; Price LL; Beaulac KR; Selker HP
    JAMA Netw Open; 2022 Feb; 5(2):e2144942. PubMed ID: 35138402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.
    Skipper CP; Pastick KA; Engen NW; Bangdiwala AS; Abassi M; Lofgren SM; Williams DA; Okafor EC; Pullen MF; Nicol MR; Nascene AA; Hullsiek KH; Cheng MP; Luke D; Lother SA; MacKenzie LJ; Drobot G; Kelly LE; Schwartz IS; Zarychanski R; McDonald EG; Lee TC; Rajasingham R; Boulware DR
    Ann Intern Med; 2020 Oct; 173(8):623-631. PubMed ID: 32673060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial.
    Oldenburg CE; Pinsky BA; Brogdon J; Chen C; Ruder K; Zhong L; Nyatigo F; Cook CA; Hinterwirth A; Lebas E; Redd T; Porco TC; Lietman TM; Arnold BF; Doan T
    JAMA; 2021 Aug; 326(6):490-498. PubMed ID: 34269813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19.
    Ruamviboonsuk P; Lai TYY; Chang A; Lai CC; Mieler WF; Lam DSC;
    Asia Pac J Ophthalmol (Phila); 2020; 9(2):85-87. PubMed ID: 32349115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018.
    Coenen S; van der Velden AW; Cianci D; Goossens H; Bongard E; Saville BR; Gobat N; de Paor M; Ieven M; Verheij TJ; Butler CC
    Br J Gen Pract; 2020 Jul; 70(696):e444-e449. PubMed ID: 32571773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azithromycin and COVID-19: Prompt early use at first signs of this infection in adults and children, an approach worthy of consideration.
    Schwartz RA; Suskind RM
    Dermatol Ther; 2020 Jul; 33(4):e13785. PubMed ID: 32510734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action.
    Khan Z; Karataş Y; Rahman H
    Adv Ther; 2020 Jun; 37(6):2575-2579. PubMed ID: 32350686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Disease on Plasma and Lung Exposure of Chloroquine, Hydroxychloroquine and Azithromycin: Application of PBPK Modeling.
    Rowland Yeo K; Zhang M; Pan X; Ban Ke A; Jones HM; Wesche D; Almond LM
    Clin Pharmacol Ther; 2020 Nov; 108(5):976-984. PubMed ID: 32531808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.